GEM 4000 A SOLUTION

SECTION 2: Hazards identification

WHMIS 2015 Classification of the mixture

Hazard categories

Hazard statement Not classified For exposure limits see section 8 Potential adverse physicochemical, human health and environmental effects see also sections 9-12) Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment

Hazard pictograms

None

Signal word

None

Hazard statements

None

Precautionary statements

None Up to 2.95% of the mixture consists of component of unknown acute toxicity (dermal, Other labeling details: inhalation) for the human health and for the aquatic environment. Use the product in accordance with the Good Laboratory Practice. Wear suitable protective clothing, gloves and eye/face protection. Do not let the product enter drainage system, surface and ground-water or soil. Do not empty into drains.

Other hazards which do not result in classification

The mixture does not meet the criteria for PBT or vPvB. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti-HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease.

2.1 Classification of the substance or mixture

This product is not hazardous according to Regulation (EC) No 1272/2008, OSHA 29 CFR 1910.1200 and Hazardous Product Regulation HPR (WHMIS 2015). Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. According to Regulation (EC) No 1272/2008, according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to Hazardous Product Regulation HPR (WHMIS 2015): Hazard class Hazard category Hazard statement Not classified For exposure limits see section 8. Potential adverse physicochemical, human health and environmental effects (see also sections 9-12) Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. 2.2 Label elements, according to Regulation (EC) No 1272/2008, according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to Hazardous Product Regulation HPR (WHMIS 2015): Hazard pictogram(s): None Signal word(s): None Hazard statement(s): None Precautionary statement(s): None Up to 2.95% of the mixture consists of component of unknown acute toxicity (dermal, Other labeling details: inhalation) for the human health and for the aquatic environment. Safety precautions: Use the product in accordance with the Good Laboratory Practice. Wear suitable protective clothing, gloves and eye/face protection. Do not let the product enter drainage system, surface and ground-water or soil. Do not empty into drains. 2.3 Other hazards (which do not results in the classification) The mixture does not meet the criteria for PBT or vPvB. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti-HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease. SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS Composition: aqueous solution containing organic and inorganic components. 3.1 Hazardous components: EINECS/ Conc. % Classification Name CAS n° 29 CFR 1910.1200 (HCS) ELINCS n° w/w* 1272/2008/EC HPR (WHMIS 2015) Calcium chloride dehydrate 233-140-8 10035-04-8 < 0.04 % Eye damage/irritation, cat. 2 Eye Irrit. 2, H319 Index N. (Annex VI of CLP Reg.) (as Calcium (10043-52-4 017-013-00-2 chloride as Calcium anhydrous) chloride anhydr.) Polyoxyethylene lauryl ether 500-002-6 9002-92-0 < 0.01% Acute Toxicity - Oral, cat 4 Acute Tox 4, H302 Eye Damage/Irritation, cat. 1 Eye Dam. 1, H318 2-octyl-2H-isothiazol-3-one 247-761-7 26350-20-1 < 0.0025% Acute Toxicity – Inhalation, Acute Tox. 2, H330 (OIT) cat. 2 Acute Tox. 3 (*), H311 Index N. (Annex VI of CLP Reg.) Acute Toxicity – Dermal, cat. 3 Acute Tox. 4 (*), H302 613-112-00-5 Acute Toxicity –Oral, cat. 4 Skin Corr. 1B, H314 Skin Corrosion/Irritation, cat.1B Skin Sens. 1, H317 Sensitization - Skin, cat. 1 Aquatic Acute 1, H400 Aquatic Acute, cat. 1** (M=100) Aquatic Chronic, cat. 1** Aquatic Chronic 1 H410 (M=10) Specific concentr. limits: Skin Sens. 1; H317: C ≥ 0,05 % Propane-1,2-diol 200-338-0 57-55-6 < 0.003% Not classified For exposure limits see ch. 8, for hazard statements text see ch. 16. * a range may be indicated, considering batch-to batch variation. **Environmental classification according to Reg. N. 1272/2008 (EC) and subsequent amendments. The mixture contains one substance listed in the Hazardous Substance Lists and/or evaluated for carcinogenicity by IARC, NTP, OSHA: propane-1,2-diol. See Section 11 and 15. SECTION 4. FIRST AID MEASURES 4.1 Description of first aid measures Ingestion: If swallowed rinse mouth with plenty of water provided person is conscious. Do not induce vomiting. Get medical advice if adverse symptoms appear. Inhalation exposure